1st Quarter - Report · 2026

Filing UUID: 088b2acd-ec4b-43df-b1f8-fc13bbff437e
Type: Q1 — 1st Quarter - Report
Period: first_quarter
Year: 2026
Posted: 2026-04-17 18:11:25
Income (reported): $50,000
Expenses (reported): —
Filing document: Open on lda.senate.gov

Registrant (lobbying firm)

HOLLAND & KNIGHT LLP

Law Firm

Contact: RICHARD GOLD
Phone: +1 202-955-3000
Address: zip:20006, city:Washington, state:DC, street:800 17th Street NW Suite 1100

Client

ALVOTECH SA

Biosimilar medicine development and manufacture

Country: IS
Effective date: 2025-12-02

Issues lobbied + lobbyists

`TRD` — Trade (domestic/foreign)

Trade policy and tariff impacts on the pharmaceutical industry.

Lobbyists: PATRICK CHILDRESS

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

1st Quarter - Report · 2026

Registrant (lobbying firm)

Client

Issues lobbied + lobbyists

TRD — Trade (domestic/foreign)

`TRD` — Trade (domestic/foreign)